|
MSH3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.86230047944025E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.24260004694821E-09 |
| Normal-vs-Stage2 |
6.356000E-04 |
| Normal-vs-Stage3 |
1.800740E-04 |
| Normal-vs-Stage4 |
3.097500000937E-08 |
| Stage1-vs-Stage2 |
5.342600E-01 |
| Stage1-vs-Stage3 |
6.904000E-01 |
| Stage1-vs-Stage4 |
2.366600E-01 |
| Stage2-vs-Stage3 |
8.452800E-01 |
| Stage2-vs-Stage4 |
2.336000E-01 |
| Stage3-vs-Stage4 |
3.024400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.07829983725583E-10 |
| Normal-vs-AfricanAmerican |
5.00089999966313E-07 |
| Normal-vs-Asian |
1.336550E-01 |
| Caucasian-vs-AfricanAmerican |
5.508000E-01 |
| Caucasian-vs-Asian |
4.924400E-01 |
| AfricanAmerican-vs-Asian |
3.752200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.31723537527751E-12 |
| Normal-vs-Female |
2.967500E-04 |
| Male-vs-Female |
1.777680E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.56849999993969E-07 |
| Normal-vs-Extreme_Weight |
1.10749964754575E-10 |
| Normal-vs-Obese |
4.78949999993539E-07 |
| Normal-vs-Extreme_Obese |
2.117100E-03 |
| Normal_Weight-vs-Extreme_Weight |
5.688000E-01 |
| Normal_Weight-vs-Obese |
3.835000E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.549600E-01 |
| Extreme_Weight-vs-Obese |
8.528400E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.884400E-01 |
| Obese-vs-Extreme_Obese |
8.607200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.440290E-04 |
| Normal-vs-Age(41-60Yrs) |
5.75249999856808E-08 |
| Normal-vs-Age(61-80Yrs) |
2.68430000449627E-09 |
| Normal-vs-Age(81-100Yrs) |
4.81039999999933E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.731600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.019000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.975600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.618020E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.774750E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.085200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.36286595529145E-12 |
| Normal-VS-Type2 PRCC |
1.80901999999872E-05 |
| Normal-VS-KIRP CIMP |
3.24079996172344E-09 |
| Normal-VS-Unclassified PRCC |
7.389500E-04 |
| Type1 PRCC-VS-Type2 PRCC |
1.164850E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.785580E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.030240E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.844880E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
6.415200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.863300E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.68129999945333E-07 |
| Normal-vs-N1 |
1.72568999999845E-05 |
| Normal-vs-N2 |
3.99539999973442E-07 |
| N0-vs-N1 |
7.804600E-01 |
| N0-vs-N2 |
3.757200E-01 |
| N1-vs-N2 |
2.412000E-01 |
|
|
